Advanced Vessel Sealing Instruments Market is segmented By Energy Type ( Bipolar, Ultrasonic, Hybrid), By Application (Laparoscopic Surgery, General Surgery), By End-User (Hospitals, Specialty Clinics, Ambulatory surgical centers), By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023- 2030.
Advanced Vessel Sealing Instruments Market
[180 Pages Report] The Advanced Vessel Sealing Instruments Market Size was valued at US$ XX billion in 2022 and is estimated to reach US$ XX billion by 2030, growing at a CAGR of 5.7 % during the forecast period (2023- 2030).
Using bipolar electrothermal energy, a vessel-sealing system can seal the vessel wall by denaturing the collagen and elastin in the wall and completely occluding the blood vessel. During liver parenchyma division, the vessel-sealing system can easily occlude vessels exposed by clamp crushing or an ultrasonic dissector.
Advanced Vessel Sealing Instruments Market Report Scope
|
Metrics |
Details |
|
Market CAGR |
5.7% |
|
Segments Covered |
By Energy Type, By Application, By End-User, and By Region |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
|
Fastest Growing Region |
Asia Pacific |
|
Largest Market Share |
North America |
To Get a Free Sample Click here
Advanced Vessel Sealing Instruments Market Dynamics
The increasing number of safe and effective technologies during surgeries will drive the market
Surgery is often the only therapy that can alleviate disabilities and reduce the risk of death from common conditions. Many millions of people undergo surgical treatment every year, and surgical interventions account for an estimated 13% of the world's total disability-adjusted life years (DALYs). However, while surgical procedures are intended to save lives, unsafe surgical care can cause substantial harm.
WHO has undertaken several global and regional initiatives to address surgical safety. Much of this work has stemmed from the WHO Second Global Patient Safety Challenge, "Safe Surgery Saves Lives." Safe Surgery Saves Lives is set about to improve surgical care safety worldwide by defining a core set of safety standards that could be applied in all WHO Member States.
With computer-aided systems such as robotics and image-guided surgery, the next generation of surgical systems will be more sophisticated and will allow surgeons to perform surgical procedures beyond the current limitations of human performance, especially at the microscale or on moving organs. As technology is constantly evolving, the latest equipment and technological breakthroughs are in vessel sealing technologies. Vessel sealing technology uses pressure and energy to seal vessels and offers significant advantages in endoscopic surgery. The further advantage of this automated system is that it eliminates guesswork by minimizing seal time and maximizing reliability.
The patented Instant Response™ technology (Valleylab, Boulder, CO, USA) features an advanced feedback system that recognizes changes in tissue 200 times per second. It adjusts the voltage and current accordingly to maintain the most appropriate power and effectively seal the vessel or tissue bundle.
Rising demand and investments in surgical instruments will drive the market in the forecast period
A surgical instrument is a specially designed tool or device used for performing specific actions of carrying out desired effects during surgery or operation, such as modifying biological tissue or providing access to or viewing it. LigaSure vessel sealing system, and vascular stapler, have permitted laparoscopy in devascularization procedures. Electrofusion Vessel Sealing device is used for sealing & cutting the vessels for varied surgical applications Laparoscopic Surgery gynecology urology cardio-surgery thoracic-surgery.
A new 3mm vessel and tissue sealer using a lower, more efficient energy profile and RF bipolar technology work safely and effectively in various cases. For example, over 1 year, 89 patients underwent laparoscopic and thoracoscopic procedures using a new 3 mm tissue sealing device. The device is a 3mm instrument with a 1 cm Maryland-style grasper/dissector capable of sealing vessels up to 5mm in diameter.
Medtech companies have been looking for updates on their instruments or new technologies to replace their current offers to comply with the FDA's recommendations. Surge-on Medical is way ahead of them. The innovative instruments were designed, taking into account the new FDA and CE guidelines for cleanable and reusable medical devices.
The high cost of the instruments and complications arising after using the devices will hamper the market
LigaSure™ 5-mm Blunt Tip laparoscopic instrument is the latest sealer/divider from Medtronic. An obvious disadvantage of the LigaSure™ device is the cost, as it is a sterile, single-use-disposable instrument. Sutureless thyroid surgery utilizing thermal sealing is now well established. However, incremental advances in technology still require formal clinical evaluation to ensure that added technology does not compromise safety.
According to a study carried out, the effects of the sealing system on bronchi were not so satisfactory. Results show that bronchi with diameter up to 2 mm in diameter, sealed by LigaSure, resisted to a pressure higher than 60 mmHg, which we conventionally considered as a "critical pressure." The sealing effect was unpredictable for bronchi with a diameter from 3 mm to 5 mm and was negligible for bronchi with a diameter ≥of 6 mm. The results suggest that this sealing system is not suitable for the closure of large bronchi, as required in significant lung resections. The initial costs for the procedures are high, and it is necessary to keep the jaws of the forceps clean to avoid the adhesion of the sealed tissue to the instrument.
COVID-19 Impact Analysis on Advanced Vessel Sealing Instruments Market
COVID-19 has impacted the healthcare systems globally, and it has significantly affected surgical practice in multiple ways. Several organizations have released recommendations and guidelines for addressing the COVID-19 pandemic. All the surgical procedures and manufacturing of medical devices for these surgeries were put on hold during COVID-19. All the surgical procedures, as well as manufacturing of medical devices for these surgeries, were put on hold during COVID-19
Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) recognizes that the COVID-19 pandemic has significantly impacted surgical practice and surgeon wellness.
On March 1st, the Centers for Disease Control and Prevention (CDC) recommended rescheduling surgeries and shifting inpatient surgical procedures to outpatient settings when feasible. To ease the decision-making process, surgical societies have established criteria for prioritization.
Advanced Vessel Sealing Instruments Market Segmentation Analysis
Bipolar energy type dominated the market
Energy-based vessel sealing devices (VSDs) have been developed to facilitate dissection and hemostasis during open and laparoscopic procedures. These technologies enable surgeons to improve the efficiency and safety of procedures with decreased blood loss and operative times. The reliability of vessel sealing using energy devices is clinically vital; the seal quality needs to be consistent in this regard.
Bipolar energy and ultrasonic devices are the most routinely used hemostatic energy devices in contemporary surgical practice. New bipolar devices utilize electrothermal energy to seal blood vessels and reduce damage to surrounding tissues by preventing electric current from spreading beyond the device's jaws. In comparison, ultrasonic devices utilize high-frequency vibrations instead of electrical current, but the energy is again limited to being delivered just between the jaws of the device with scant lateral spread.
The novel laparoscopic, bipolar electrosurgical sealing and cutting instrument BiCision® was compared to a commercially available laparoscopic device (EnSeal(™)) on visceral and peripheral arteries and veins in an animal model. BiCision® appeared to be as good as or even superior to EnSeal(™). Since EnSeal(™) has already been shown to be safe and has been successfully used in clinical practice, BiCision® is assumed to be as efficient and reliable as EnSeal(™) under pre-clinical conditions.
Laparoscopic surgery will dominate the market in the forecast period
Laparoscopic or "minimally invasive" surgery is a specialized technique for performing surgery. Advanced vessel sealing instruments are a significant part of the laparoscopic surgeries performed. Cutting, coagulation, and dissection are some paramount qualities of vessel sealing instruments. Laparoscopic vessel sealing devices have revolutionized modern laparoscopy. Likewise, minimally invasive technology has revolutionized all surgical approaches in the current century. Energy sources form a vital part of laparoscopic surgeries in achieving hemostasis and providing a bloodless field to operate.
Achieving good hemostasis is the cornerstone of any successful surgery. At the beginning years of laparoscopy, suturing, titanium clips and laparoscopic stapling devices were used to achieve hemostasis. The use of electrosurgery for hemostasis was a milestone in the history of laparoscopy.
The suitable hemostasis vessel sealing instruments are during laparoscopy to produce minimal thermal spread and are effective ≤7 mm in diameter, work quickly and produce consistent results.
The hospital segment dominated the market
The increased adoption of technologically advanced products, patient care and focus on positive medical outcomes in hospitals will dominate this market. Most vessel sealing devices are made for a single-use; their application is cost-intensive so, they should be carefully handled by a trained healthcare professional. The processes of sterilization and decontamination are complex, require specific infrastructure and equipment and involve several steps that need to be correct, from devices collection, receipt by the unit, processing, storage and distribution throughout the facility. Of utmost importance are also quality control procedures to assess the correct functioning of the equipment. For optimal and safe use of this device, a healthcare professional must handle it in a hospital setting. All these factors will lead to the growth of this segment.
Advanced Vessel Sealing Instruments Market Geographical Share
North America will dominate the advanced vessel sealing market
Availability of technologically advanced medical facilities, rising incidences of surgeries and awareness related to the advantages of vessel sealing instruments will rise the market in this region. Technological advances and increased number of FDA approval. The presence of most of the key players in this region is one more factor that will drive its market growth.
The US Food and Drug Administration has currently approved the Enseal tissue-sealing device (Ethicon Endo-Surgery, Blue Ash, Ohio) for vessels up to 7 mm in diameter. This is greater than or equal to the vessel diameter limit in other vessel-sealing systems widely used, such as Ligasure (Covidien, Boulder, Colorado) and the Harmonic Scalpel (Ethicon Endo-Surgery). Anecdotal evidence suggests that the Enseal device can safely seal vessels >7 mm.
Advanced Vessel Sealing Instruments Market Competitive Landscape
Advanced vessel sealing instruments market key players are Intuitive Surgical, Inc, Johnson & Johnson Services Inc, Pfizer Inc, Lupin, Siemens, Koninklijke Philips NV, Intuitive Surgical, Inc, Cook, Medtronic, Teva Pharmaceutical Industries Ltd, Medsinglong Co Ltd., Guangzhou Medunion Technologies Co.ltd and Guangzhou Maya Medical Equipment.Co.ltd.
Advanced Vessel Sealing Instruments Market. Companies to Watch
Intuitive Surgical, Inc
Overview: Intuitive headquartered in Sunnyvale, California, is a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery. The intuitive company believes that minimally invasive care is life-enhancing care. Through ingenuity and intelligent technology, it helps to expand the potential of physicians to heal without constraints. Intuitive brings more than two decades of leadership in robotic-assisted surgical technology and solutions to its offerings and develops, manufactures, and markets the da Vinci surgical system and the Ion endoluminal system.
Product Portfolio: The company offers minimally invasive surgical systems cleared by the FDA,robotic-assisted surgical technologies develop, manufactures, and markets the da Vinci surgical system. It also offers vessel sealing and closure instruments like Da Vinci vessel sealer extend.
Key Development: In December 2018 Intuitive Surgical, Inc received U.S FDA approval for their vessel sealer extend intended for grasping and blunt dissection for tissue and bipolar coagulation.
